Ligand Pharmaceuticals Statistics
Total Valuation
MKTX has a market cap or net worth of $7.07 billion. The enterprise value is $6.58 billion.
| Market Cap | 7.07B |
| Enterprise Value | 6.58B |
Important Dates
The last earnings date was Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Aug 20, 2025 |
Share Statistics
MKTX has 37.36 million shares outstanding. The number of shares has decreased by -0.60% in one year.
| Current Share Class | 37.36M |
| Shares Outstanding | 37.36M |
| Shares Change (YoY) | -0.60% |
| Shares Change (QoQ) | -0.42% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 101.21% |
| Float | 36.62M |
Valuation Ratios
The trailing PE ratio is 31.78 and the forward PE ratio is 24.19. MKTX's PEG ratio is 6.12.
| PE Ratio | 31.78 |
| Forward PE | 24.19 |
| PS Ratio | 8.41 |
| Forward PS | 7.62 |
| PB Ratio | 5.08 |
| P/TBV Ratio | 7.23 |
| P/FCF Ratio | 17.66 |
| P/OCF Ratio | 17.47 |
| PEG Ratio | 6.12 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.59, with an EV/FCF ratio of 16.42.
| EV / Earnings | 29.52 |
| EV / Sales | 7.86 |
| EV / EBITDA | 15.59 |
| EV / EBIT | 18.94 |
| EV / FCF | 16.42 |
Financial Position
The company has a current ratio of 7.55, with a Debt / Equity ratio of 0.05.
| Current Ratio | 7.55 |
| Quick Ratio | 6.15 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.17 |
| Interest Coverage | 341.81 |
Financial Efficiency
Return on equity (ROE) is 16.33% and return on invested capital (ROIC) is 15.10%.
| Return on Equity (ROE) | 16.33% |
| Return on Assets (ROA) | 11.24% |
| Return on Invested Capital (ROIC) | 15.10% |
| Return on Capital Employed (ROCE) | 19.33% |
| Revenue Per Employee | $939,570 |
| Profits Per Employee | $250,103 |
| Employee Count | 891 |
| Asset Turnover | 0.43 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MKTX has paid $148.19 million in taxes.
| Income Tax | 148.19M |
| Effective Tax Rate | 39.94% |
Stock Price Statistics
The stock price has decreased by -20.27% in the last 52 weeks. The beta is 0.84, so MKTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.84 |
| 52-Week Price Change | -20.27% |
| 50-Day Moving Average | 214.21 |
| 200-Day Moving Average | 224.41 |
| Relative Strength Index (RSI) | 30.31 |
| Average Volume (20 Days) | 546,265 |
Short Selling Information
The latest short interest is 1.30 million, so 3.47% of the outstanding shares have been sold short.
| Short Interest | 1.30M |
| Short Previous Month | 1.38M |
| Short % of Shares Out | 3.47% |
| Short % of Float | 3.54% |
| Short Ratio (days to cover) | 3.62 |
Income Statement
In the last 12 months, MKTX had revenue of $837.16 million and earned $222.84 million in profits. Earnings per share was $5.95.
| Revenue | 837.16M |
| Gross Profit | 517.76M |
| Operating Income | 347.28M |
| Pretax Income | 338.61M |
| Net Income | 222.84M |
| EBITDA | 421.98M |
| EBIT | 347.28M |
| Earnings Per Share (EPS) | $5.95 |
Balance Sheet
The company has $563.16 million in cash and $69.26 million in debt, giving a net cash position of $493.90 million or $13.22 per share.
| Cash & Cash Equivalents | 563.16M |
| Total Debt | 69.26M |
| Net Cash | 493.90M |
| Net Cash Per Share | $13.22 |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 37.05 |
| Working Capital | 1.17B |
Cash Flow
In the last 12 months, operating cash flow was $404.68 million and capital expenditures -$4.19 million, giving a free cash flow of $400.49 million.
| Operating Cash Flow | 404.68M |
| Capital Expenditures | -4.19M |
| Free Cash Flow | 400.49M |
| FCF Per Share | $10.72 |
Margins
Gross margin is 61.85%, with operating and profit margins of 41.48% and 26.62%.
| Gross Margin | 61.85% |
| Operating Margin | 41.48% |
| Pretax Margin | 44.32% |
| Profit Margin | 26.62% |
| EBITDA Margin | 50.41% |
| EBIT Margin | 41.48% |
| FCF Margin | 47.84% |
Dividends & Yields
This stock pays an annual dividend of $3.04, which amounts to a dividend yield of 1.61%.
| Dividend Per Share | $3.04 |
| Dividend Yield | 1.61% |
| Dividend Growth (YoY) | 2.72% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 50.72% |
| Buyback Yield | 0.60% |
| Shareholder Yield | 2.21% |
| Earnings Yield | 3.15% |
| FCF Yield | 5.66% |
Analyst Forecast
The average price target for MKTX is $229.70, which is 21.38% higher than the current price. The consensus rating is "Hold".
| Price Target | $229.70 |
| Price Target Difference | 21.38% |
| Analyst Consensus | Hold |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 8.29% |
| EPS Growth Forecast (5Y) | 11.04% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MKTX has an Altman Z-Score of 11.88 and a Piotroski F-Score of 4.
| Altman Z-Score | 11.88 |
| Piotroski F-Score | 4 |